Influence of Participant Perceptions of Adherence-Related Interactions with Study/Study Team on Drug Levels: HPTN069 Analysis of Self-Reported Adherence Experiences While on Study

By sjmartinez • November 11, 2023

Amico KR, Mayer KH, Landovitz RJ, Marzinke M, Hendrix C, McCauley M, Wilkin T, Gulick R; HPTN 069/A5305 study team. Influence of Participant Perceptions of Adherence-Related Interactions with Study/Study Team on Drug Levels: HPTN069 Analysis of Self-Reported Adherence Experiences While on Study. AIDS Behav. 2023 Nov 10. doi: 10.1007/s10461-023-04215-9. Epub ahead of print. PMID: 37947968.

Tags: Adherence, Drug concentration, HPTN069, Infectious Diseases, Participant-centered, Person-centered, PrEP, Publications

Incidence, risk factors, and cardiovascular impact of hypertension in people with HIV: a secondary analysis of the REPRIEVE trial

Martínez E, Watanabe M, Hoffman R, Zanni MV, Pozniak A, Shakil SS, McCallum S, Chu SM, Srinivasa S, Malvestutto CD, Fichtenbaum CJ, Bloomfield GS, Sponseller[...]

Missed Opportunities for HIV and Syphilis Co-Testing in Emergency Departments

Sherwood K, Zhang N, David H, Dekker A, Garner O, Samuels E, Adamson P. Missed Opportunities for HIV and Syphilis Co-Testing in Emergency Departments. Clin[...]

Virulence Phenotypes Differentiate Persistent vs. Resolving Isolates of Human Staphylococcus aureusBacteremia

Chan LC, Lee HK, Wang L, Wang H, Filler SG, Ciranna A, Abdelhady W, Xiong YQ, Li L, Gonzales RA, Ruffin F, Fowler VG Jr,[...]